Indivior Pharmaceuticals Inc Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc

INDV

Rankning i aktier #3858
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aktiekurs
$34.51
Marknadsvärde
$4.31B
Förändring (1 dag)
1.89%
Förändring (1 år)
42.07%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)

Kategori

Healthcare
P/S-tal för Indivior Pharmaceuticals Inc (INDV)
P/S-tal per October 2026 TTM: 3.20
Enligt Indivior Pharmaceuticals Inc senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 3.20. I slutet av 2023 hade företaget ett P/S-tal på 1.94.
Historik för P/S-tal för Indivior Pharmaceuticals Inc från 2016 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 3.20 131.87%
2024 1.38 -28.93%
2023 1.94 -43.14%
2022 3.42 5.76%
2021 3.23 106.90%
2020 1.56 235.34%
2019 0.47 -54.45%
2018 1.02 -70.40%
2017 3.45 30.98%
2016 2.64 0.00%
P/S-tal för liknande företag eller konkurrenter